HARSCO CORP (HSC)       4.41  -0.2 (-4.34%)

4.41  -0.2 (-4.34%)

US4158641070 - Common Stock - After market: 4.41 0 (0%)


Fundamental Rating

3

Overall HSC gets a fundamental rating of 3 out of 10. We evaluated HSC against 98 industry peers in the Commercial Services & Supplies industry. Both the profitability and financial health of HSC have multiple concerns. A decent growth rate in combination with a cheap valuation! Better keep an eye on HSC.




Profitability

Profitability Rating

0

The profitability ratios for HSC are negative, so there is not much use analyzing them.
HSC has a Return On Assets of -5.80%. This is below the industry average of -0.15%.

HSC's Profit Margin of -9.63% is worse than the rest of the industry. The industry average Profit Margin is 0.50%.
HSC has a very weak Piotroski-F score of 2.00. This is an indication of health and profitability issues for HSC.
VS Industry

ROA (-5.8%) VS Industry: 27% outperformed.

-156.69
20.53

Profit Margin (-9.63%) VS Industry: 25% outperformed.

-7,721.47
48.60

Valuation

Valuation Rating

8

With a Price/Earnings Ratio of 10.50, the valuation of HSC can be described as very reasonable.
Compared to an average industry Price/Earning Ratio of 16.19, HSC is valued a bit cheaper than its industry peers.
With a Forward Price/Earnings Ratio of 11.20, the valuation of HSC can be described as very reasonable.
HSC's low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

When comparing the current price to the book value of HSC, it is valued rather cheaply. It is trading at 0.59 times its book value.
When comparing the price book ratio of HSC to the average industry price book ratio of 1.88, HSC is valued rather cheaply. HSC is also cheaper than 90% of the companies listed in the same industry.
When comparing the Enterprise Value to EBITDA ratio of HSC to the average industry ratio of 9.83, HSC is valued rather cheaply.
VS Industry

Price/Earnings (10.5) VS Industry: 71% outperformed.

131.65
3.68

Price/Book (0.59) VS Industry: 90% outperformed.

80.31
0.16

Enterprise Value/ EBITDA (7.17) VS Industry: 67% outperformed.

144.50
0.19

Growth

Growth Rating

4

Measured over the past 5 years, HSC shows a quite strong growth in Earnings Per Share. The EPS has been growing by 12.11% on average per year.
HSC is expected to show a strong growth in Earnings Per Share. In the coming 5 years, the EPS will grow by 31.76% yearly.
When comparing the EPS growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
Measured over the past 5 years, HSC shows a small growth in Revenue. The Revenue has been growing by 4.96% on average per year.

HSC is expected to show a decrease in Revenue. In the coming 5 years, the Revenue will decrease by -0.55% yearly.
HSC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -33.33%.
HSC shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -16.46%.
The Revenue growth is decreasing: in the next 5 years the growth will be less than in the last years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS12.11% -13.43% -33.33% -106.96% -31.94% -13.75% 31.76%
Revenue4.96% 11.11% -16.46% -8.79% -3.32% -1.81% -0.55%

Health

Health Rating

3

A Current Ratio of 1.32 indicates that HSC should not have too much problems paying its short term obligations.
HSC has a Current Ratio comparable to the industry average, which is at 1.35.
A Quick Ratio of 1.18 indicates that HSC should not have too much problems paying its short term obligations.
The Quick Ratio is in line with the industry averages, which is at 1.13.

The Altman-Z score is in line with the industry averages, which is at 1.62.
HSC has one of the worst Debt to Equity ratios in its industry. 86% of its industry peers require less debt for financing their operations.
HSC has an Altman-Z score of 1.53. This is a bad value and indicates that HSC is not financially healthy and even has some risk of bankruptcy.
The Piotroski-F score of HSC is 2.00. This is a very weak score and indicates problems in health and profitability for HSC.
VS Industry

Debt/Equity (2.2) VS Industry: 14% outperformed.

49.71
0.00

Quick Ratio (1.18) VS Industry: 51% outperformed.

0.02
44.95

Current Ratio (1.32) VS Industry: 47% outperformed.

0.03
44.95

Altman-Z (1.53) VS Industry: 46% outperformed.

-37.94
25.15

Dividend

Dividend Rating

0

HSC does not give a dividend.

HSC Daily chart

HARSCO CORP4.41

NYSE:HSC (10/7/2022, 3:10:05 PM)-0.2 (-4.34%)

After market: 4.41 0 (0%)

Chartmill FA Rating
GICS Sector Industrials
GICS IndustryGroup Commercial & Professional Services
GICS Industry Commercial Services & Supplies
Earnings (Last) 08-02 2022-08-02/bmo Earnings (Next) 10-31 2022-10-31
Ins Owners 1.62% Inst Owners 87.12%
Market Cap 350.29M Analysts 80
Valuation
PE 10.5 Fwd PE 11.2
PEG (NY) N/A PEG (5Y) 0.87
P/S 0.21 P/B 0.59
EV/EBITDA 7.17
Dividend
Dividend Yield N/A Dividend Growth N/A
DP 0% Ex-Date N/A
Growth
EPS 1Y -33.33% EPS 3Y -13.43%
EPS 5Y 12.11% EPS growth Q2Q -96.43%
EPS Next Y -106.96% EPS Next 2Y -31.94%
EPS Next 3Y -13.75% EPS Next 5Y 31.76%
Revenue growth 1Y -16.46% Revenue growth 3Y 11.11%
Revenue growth 5Y 4.96% Revenue growth Q2Q 2.64%
Revenue Next Year -8.79% Revenue Next 2Y -3.32%
Revenue Next 3Y -1.81% Revenue Next 5Y -0.55%
Health
Current Ratio 1.32 Quick Ratio 1.18
Altman-Z 1.53 F-Score 2
Debt/Equity 2.2 WACC 6.02%
ROIC/WACC 0.53
Profitability
ROA -5.8% ROE N/A
ROIC 3.21% ROICg 1.54%
PM -9.63% OM 2.67%
Asset Turnover 0.6

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA